UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
GC sells off North America business to Grifols
GC said that it has sold off its Montreal-based GC Biotherapeutics’ plasma ...
by Lee Han-soo
|
2020-07-21 18:31
라인
Helixmith to start trials of VM202 for treating rare disorder
Helixmith said that it has kicked off its phase 1 and 2a clinical trial for...
by Lee Han-soo
|
2020-07-21 17:10
라인
Genexine, Y Biologics to co-develop Covid-19 treatment
Genexine said that it would develop an antibody-based Covid-19 treatment, j...
by Lee Han-soo
|
2020-07-21 15:52
라인
GC LabCell’s tech wins patent for delivering gene therapy to brain
GC Labcell said Tuesday that it obtained a domestic patent for a compositio...
by Shim Hyun-tai
|
2020-07-21 15:52
라인
'Severe atopic dermatitis drug too expensive for adolescents'
The drug regulator expanded approval for Dupixent (ingredient: dupilumab), ...
by Kim Eun-young
|
2020-07-21 14:20
라인
GC makes plasma Covid-19 therapy for clinical trials
GC Pharma has taken the first step to commercialize its new plasma treatmen...
by Shim Hyun-tai
|
2020-07-20 17:30
라인
Eutilex’s cancer therapy won Canadian patent
Eutilex, a biotechnology firm specializing in cancer immunotherapy, said Fr...
by Shim Hyun-tai
|
2020-07-17 17:52
라인
Hanmi’s fatty liver drug won FDA’s fast-track designation
Hanmi Pharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Shim Hyun-tai
|
2020-07-16 15:57
라인
‘Stage-3 unresectable lung cancer patient has every reason to use Imfinzi’
“Before Imfinzi arrived, all physicians could do for a state-3 unresectable...
by Kim Yun-mi
|
2020-07-16 14:37
라인
Menarini Korea deletes controversial YouTube ad
Menarini Korea’s online advertisement of an athlete’s foot treatment depict...
by Kim Chan-hyuk
|
2020-07-16 14:16
라인
Samsung Biologics to develop 5 more cancer therapies of ImmuneOncia
Samsung Biologics said Wednesday that it has signed a CDO (contract develop...
by Shim Hyun-tai
|
2020-07-15 18:33
라인
Biogen, Esai to test another Alzheimer’s drug in phase-3 study
Biogen and Eisai, whose collaboration for experimental Alzheimer’s drug adu...
by Kim Yun-mi
|
2020-07-15 12:42
라인
Medytox, Daewoong keep brawling over US agency’s ruling
Medytox and Daewoong Pharmaceutical continued to brawl over the U.S. Intern...
by Lee Han-soo
|
2020-07-14 17:30
라인
Hanmi Science, Bioapp to start full-scale development of Green bio-based COVID-19 vaccine
Hanmi Science (CEO Lim Chong-yoon, Hanmi Group Holding Company) and a promi...
by Lee Han-soo
|
2020-07-14 14:58
라인
LSK Global PS chosen as CRO of IVI's Covid-19 vaccine trials
LSK Global Pharma Services (PS) said that it would conduct and support the ...
by Lee Han-soo
|
2020-07-13 15:48
라인
‘Remdesivir cut death risk by 62% in severely ill Covid-19 patients’
Gilead Sciences said its Covid-19 drug candidate remdesivir reduced the ris...
by Kim Yun-mi
|
2020-07-13 14:44
라인
Regulator OKs Samyang’s breast cancer treatment
Samyang Biopharmaceuticals said that the Ministry of Food and Drug Safety h...
by Lee Han-soo
|
2020-07-13 14:38
라인
Multinational drugmakers seek to form new trade union
Some workers at the Korean offshoots of multinational pharmaceutical compan...
by Kim Yun-mi
|
2020-07-13 11:44
라인
Ministry OKs Dongkook's P3 trial into benign prostatic hyperplasia treatment
Dongkook Pharmaceutical said that the Ministry of Food and Drug Safety has ...
by Lee Han-soo
|
2020-07-10 16:54
라인
Court rejects Medytox's request not to revoke license of Medytoxin
A local court on Wednesday has turned down Medytox's appeal for suspend...
by Lee Han-soo
|
2020-07-10 14:59
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top